Fairfield, Bush & Co. Viatris Inc Transaction History

Fairfield, Bush & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$8.77 - $10.85 $13,155 - $16,275	1,500 New	1,500 $16.2 Million
Q2 2023 Aug 15, 2023	BUY	$9.02 - $10.29 $91,363 - $104,227	10,129 New	10,129 $101 Million
Q2 2022 Aug 09, 2022	SELL	$9.95 - $12.27 $3,761 - $4,638	-378 Reduced 18.7%	1,643 $17,000
Q1 2022 May 06, 2022	BUY	$9.81 - $15.4 $19,826 - $31,123	2,021 New	2,021 $22,000

1,103

931M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

Stay updated on Fairfield, Bush & Co. with notifications on news.